Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1999
11/30/1999US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999US5993817 Method to ameliorate osteolysis and metastasis
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993813 Family of high affinity, modified antibodies for cancer treatment
11/30/1999US5993774 Metal-oxime chelates for use as radiopharmaceutical agents
11/30/1999CA1340834C Derivatives of human/bovine basic fibroblast growth factor
11/30/1999CA1340833C Activated killer monocytes: tumoricidal activity and method of monitoring same
11/25/1999WO1999060407A1 Assays, methods and means for modulating e2f activity
11/25/1999WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999WO1999060142A2 Gene therapy vectors and their use in antitumour therapy
11/25/1999WO1999060133A2 Human nucleic acid methylases
11/25/1999WO1999060128A1 Il-2 selective agonists and antagonists
11/25/1999WO1999060023A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999060013A2 Il-6 antagonist peptides
11/25/1999WO1999060012A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999WO1999060008A1 Cytosine deaminase gene
11/25/1999WO1999059996A1 Antitumour 1,5-diazaanthraquinones
11/25/1999WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999WO1999059987A1 5-demethoxyfumagillol derivatives and processes for preparing the same
11/25/1999WO1999059986A1 Fumagillol derivatives and processes for preparing the same
11/25/1999WO1999059981A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059640A2 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
11/25/1999WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999WO1999059628A2 Combination therapy for the treatment of tumors
11/25/1999WO1999059624A2 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia
11/25/1999WO1999059620A1 Angiostatin receptor
11/25/1999WO1999059609A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059605A1 Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases
11/25/1999WO1999059604A1 Adenovirus-chemotherapeutic combination for treating cancer
11/25/1999WO1999059599A1 Edelfosin for the treatment of brain tumours
11/25/1999WO1999059578A1 Triterpene compositions and methods for use thereof
11/25/1999WO1999059565A1 Novel compositions
11/25/1999WO1999059526A2 Protease inhibitors
11/25/1999WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999WO1999049859A9 Dfmo and sulindac combination in cancer chemoprevention
11/25/1999WO1999048515A9 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999047158A3 Therapeutic chemokine receptor antagonists
11/25/1999WO1999043832A3 Human proteinase molecules
11/25/1999WO1999042834A3 Treating cancer
11/25/1999WO1999042602A3 Fermentative preparation process for cytostatics and crystal forms thereof
11/25/1999WO1999040881A3 Specific antibodies against mammary tumor-associated mucin, method for production and use
11/25/1999WO1999039740A9 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/25/1999DE19823679A1 Herbal preparation useful for prophylaxis and/or therapy of tumors
11/25/1999DE19822509A1 Use of edelfosin for treatment of brain tumors, especially by oral administration
11/25/1999DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells
11/25/1999CA2690399A1 Il-6 antagonist peptides
11/25/1999CA2374248A1 Gene therapy vectors and their use in antitumour therapy
11/25/1999CA2345917A1 Antitumour 1,5-diazaanthraquinones
11/25/1999CA2333274A1 Thermally stable trimetrexates and processes for producing the same
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332531A1 Protease inhibitors
11/25/1999CA2332507A1 Angiostatin receptor
11/25/1999CA2332331A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2329901A1 Assays, methods and means for modulating e2f activity
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999CA2328603A1 Novel compositions comprising interleukin-18 and a chemotherapeutic agent
11/25/1999CA2328596A1 Cytosine deaminase gene
11/25/1999CA2328510A1 Human nucleic acid methylases
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/25/1999CA2328057A1 Composition for the induction of a tumour-specific immune response, methods for its production and use of composition for the treatment of neoplasia
11/25/1999CA2326323A1 Adenovirus-chemotherapeutic combination for treating cancer
11/24/1999EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0958365A1 Granulocyte chemotactic protein 2 variant
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999EP0958363A1 Human regulator of g-protein signaling - (hrgs)
11/24/1999EP0958307A1 O-sulfated bacterial polysaccharides
11/24/1999EP0958305A2 Inhibitions of the interaction between p53 and mdm2
11/24/1999EP0958304A1 Nucleotide sequence encoding the cd33-like protein
11/24/1999EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE
11/24/1999EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
11/24/1999EP0957924A1 Certain phosphinyl derivatives useful as naaladase inhibitors
11/24/1999EP0957920A1 Reducing toxic effects of carboplatin using dithioethers
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/24/1999EP0957912A1 Pharmaceutical compounds
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0822831B1 Vaccines containing a saponin and a sterol
11/24/1999EP0730470A4 Improved interferon polymer conjugates
11/24/1999EP0633893B1 17-substituted steroids useful in cancer treatment
11/24/1999CN1236369A New Knoevenagel condensation products, method for their production and use
11/24/1999CN1236365A Substituted benzocycloheptapyridine useful as inhibitors of Farnesyl protein transferase
11/24/1999CN1236364A Substituted benzocycloheptapyridine derivatives useful for inhibition of Farnesyl protein transferase
11/24/1999CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
11/24/1999CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
11/24/1999CN1235973A Sidechain-bearing taxanes
11/24/1999CN1235826A 10, 11 methanodibenzosuberane derivatives used as chemosensitizing agents
11/24/1999CN1046737C Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
11/24/1999CN1046731C Pyrrolo [2,3-d] pyrimidines and their use
11/24/1999CN1046710C aminopyridines, process for preparing the same and use and medicaments containing the same
1 ... 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 ... 2211